Midday Losers; Momenta Pharmaceuticals Down -23.32%

by Eddie Staley, Benzinga Editor
September 19, 2011 12:39 PM | 25 seconds read |
Momenta Pharmaceuticals MNTA -23.32% after FDA approves Lovenox generic drug. AsiaInfo-Linkage ASIA -13.84% - hearing the company was downgraded to Neutral at Susquehanna. ING Groep ING -9.03% on the European debt concerns. Barclays BCS -8.12% on the European debt concerns. Credit Suisse CS -8.04% on the European debt concerns. Monster Worldwide MWW -9.11%
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Posted In: Intraday UpdateMovers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!